CLGN - Company ID 0001631487
The table below shows CollPlant Biotechnologies Ltd's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.59M | $11.91M | $26.67M | $29.65M | $13.15M | $3.33M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.00K | $150.00K | $9.00K | $9.00K | $270.00K | $830.00K |
| Inventory | $573.00K | $440.00K | $714.00K | $1.43M | $1.08M | $1.26M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $6.75M |
| $13.18M |
| $28.02M |
| $31.66M |
| $45.09M |
| $5.68M |
| Property, plant & equipment | $1.46M | $2.29M | $2.79M | $2.97M | $2.73M | $2.11M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $10.79M | $18.71M | $34.13M | $37.77M | $51.22M | $10.84M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $2.67M | $2.97M | $3.25M | $3.10M | $3.01M | $3.39M |
| Long-term debt | - | - | - | - | $30.00K | $3.38M |
| Total liabilities | $4.70M | $5.25M | $5.79M | $5.49M | $6.10M | $6.36M |
| Retained earnings | -$124.84M | -$113.35M | -$96.74M | -$89.72M | -$72.80M | -$73.03M |
| Total equity | $6.08M | $13.46M | $28.34M | $32.28M | $45.12M | $4.48M |